Global (United States, European Union and China) Solid Tumor Drug Market Research Report 2019-2025

Table of Contents

1 Solid Tumor Drug Market Overview

• 1.1 Product Overview and Scope of Solid Tumor Drug
• 1.2 Solid Tumor Drug Segment by Type
  • 1.2.1 Global Solid Tumor Drug Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Small Molecules
  • 1.2.3 Biologics
• 1.3 Solid Tumor Drug Segment by Application
  • 1.3.1 Solid Tumor Drug Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Oncology
  • 1.3.3 Neurology
  • 1.3.4 Radiology
  • 1.3.5 Others
• 1.4 Global Solid Tumor Drug Market Size Estimates and Forecasts
  • 1.4.1 Global Solid Tumor Drug Revenue 2015-2026
  • 1.4.2 Global Solid Tumor Drug Sales 2015-2026
  • 1.4.3 Solid Tumor Drug Market Size by Region: 2020 Versus 2026

2 Global Solid Tumor Drug Market Competition by Manufacturers

• 2.1 Global Solid Tumor Drug Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Solid Tumor Drug Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Solid Tumor Drug Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Solid Tumor Drug Manufacturing Sites, Area Served, Product Type
• 2.5 Solid Tumor Drug Market Competitive Situation and Trends
  • 2.5.1 Solid Tumor Drug Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Solid Tumor Drug Players (Opinion Leaders)

3 Solid Tumor Drug Retrospective Market Scenario by Region

• 3.1 Global Solid Tumor Drug Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Solid Tumor Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Solid Tumor Drug Market Facts & Figures by Country
  • 3.3.1 North America Solid Tumor Drug Sales by Country
  • 3.3.2 North America Solid Tumor Drug Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Solid Tumor Drug Market Facts & Figures by Country
  • 3.4.1 Europe Solid Tumor Drug Sales by Country
  • 3.4.2 Europe Solid Tumor Drug Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Solid Tumor Drug Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Solid Tumor Drug Sales by Region
  • 3.5.2 Asia Pacific Solid Tumor Drug Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Solid Tumor Drug Market Facts & Figures by Country
  • 3.6.1 Latin America Solid Tumor Drug Sales by Country
  • 3.6.2 Latin America Solid Tumor Drug Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Solid Tumor Drug Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Solid Tumor Drug Sales by Country
  • 3.7.2 Middle East and Africa Solid Tumor Drug Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Solid Tumor Drug Historic Market Analysis by Type

• 4.1 Global Solid Tumor Drug Sales Market Share by Type (2015-2020)
• 4.2 Global Solid Tumor Drug Revenue Market Share by Type (2015-2020)
• 4.3 Global Solid Tumor Drug Price Market Share by Type (2015-2020)
• 4.4 Global Solid Tumor Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Solid Tumor Drug Historic Market Analysis by Application

• 5.1 Global Solid Tumor Drug Sales Market Share by Application (2015-2020)
• 5.2 Global Solid Tumor Drug Revenue Market Share by Application (2015-2020)
• 5.3 Global Solid Tumor Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Solid Tumor Drug Business

• 6.1 AstraZeneca
  • 6.1.1 Corporation Information
  • 6.1.2 AstraZeneca Description, Business Overview and Total Revenue
  • 6.1.3 AstraZeneca Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 AstraZeneca Products Offered
  • 6.1.5 AstraZeneca Recent Development
• 6.2 Biogen
  • 6.2.1 Biogen Solid Tumor Drug Production Sites and Area Served
  • 6.2.2 Biogen Description, Business Overview and Total Revenue
  • 6.2.3 Biogen Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Biogen Products Offered
  • 6.2.5 Biogen Recent Development
• 6.3 Baxter
  • 6.3.1 Baxter Solid Tumor Drug Production Sites and Area Served
  • 6.3.2 Baxter Description, Business Overview and Total Revenue
  • 6.3.3 Baxter Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Baxter Products Offered
  • 6.3.5 Baxter Recent Development
• 6.4 Celgene Corporation
  • 6.4.1 Celgene Corporation Solid Tumor Drug Production Sites and Area Served
  • 6.4.2 Celgene Corporation Description, Business Overview and Total Revenue
  • 6.4.3 Celgene Corporation Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Celgene Corporation Products Offered
  • 6.4.5 Celgene Corporation Recent Development
• 6.5 Abbott Laboratories
  • 6.5.1 Abbott Laboratories Solid Tumor Drug Production Sites and Area Served
  • 6.5.2 Abbott Laboratories Description, Business Overview and Total Revenue
  • 6.5.3 Abbott Laboratories Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Abbott Laboratories Products Offered
  • 6.5.5 Abbott Laboratories Recent Development
• 6.6 Pfizer Inc
  • 6.6.1 Pfizer Inc Solid Tumor Drug Production Sites and Area Served
  • 6.6.2 Pfizer Inc Description, Business Overview and Total Revenue
  • 6.6.3 Pfizer Inc Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Pfizer Inc Products Offered
  • 6.6.5 Pfizer Inc Recent Development
• 6.7 Amgen Limited & Amgen Ireland Limited
  • 6.6.1 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Production Sites and Area Served
  • 6.6.2 Amgen Limited & Amgen Ireland Limited Description, Business Overview and Total Revenue
  • 6.6.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Amgen Limited & Amgen Ireland Limited Products Offered
  • 6.7.5 Amgen Limited & Amgen Ireland Limited Recent Development
• 6.8 Bristol-Myers Squibb Company
  • 6.8.1 Bristol-Myers Squibb Company Solid Tumor Drug Production Sites and Area Served
  • 6.8.2 Bristol-Myers Squibb Company Description, Business Overview and Total Revenue
  • 6.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Bristol-Myers Squibb Company Products Offered
  • 6.8.5 Bristol-Myers Squibb Company Recent Development
• 6.9 GlaxoSmithKline plc.
  • 6.9.1 GlaxoSmithKline plc. Solid Tumor Drug Production Sites and Area Served
  • 6.9.2 GlaxoSmithKline plc. Description, Business Overview and Total Revenue
  • 6.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 GlaxoSmithKline plc. Products Offered
  • 6.9.5 GlaxoSmithKline plc. Recent Development
• 6.10 F. Hoffmann-La Roche Ltd.
  • 6.10.1 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Production Sites and Area Served
  • 6.10.2 F. Hoffmann-La Roche Ltd. Description, Business Overview and Total Revenue
  • 6.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 F. Hoffmann-La Roche Ltd. Products Offered
  • 6.10.5 F. Hoffmann-La Roche Ltd. Recent Development
• 6.11 Eli Lilly and Company
  • 6.11.1 Eli Lilly and Company Solid Tumor Drug Production Sites and Area Served
  • 6.11.2 Eli Lilly and Company Solid Tumor Drug Description, Business Overview and Total Revenue
  • 6.11.3 Eli Lilly and Company Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Eli Lilly and Company Products Offered
  • 6.11.5 Eli Lilly and Company Recent Development
• 6.12 Johnson & Johnson
  • 6.12.1 Johnson & Johnson Solid Tumor Drug Production Sites and Area Served
  • 6.12.2 Johnson & Johnson Solid Tumor Drug Description, Business Overview and Total Revenue
  • 6.12.3 Johnson & Johnson Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Johnson & Johnson Products Offered
  • 6.12.5 Johnson & Johnson Recent Development

7 Solid Tumor Drug Manufacturing Cost Analysis

• 7.1 Solid Tumor Drug Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Solid Tumor Drug
• 7.4 Solid Tumor Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Solid Tumor Drug Distributors List
• 8.3 Solid Tumor Drug Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Solid Tumor Drug Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Solid Tumor Drug by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Solid Tumor Drug by Type (2021-2026)
• 10.2 Solid Tumor Drug Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Solid Tumor Drug by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Solid Tumor Drug by Application (2021-2026)
• 10.3 Solid Tumor Drug Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Solid Tumor Drug by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Solid Tumor Drug by Region (2021-2026)
• 10.4 North America Solid Tumor Drug Estimates and Projections (2021-2026)
• 10.5 Europe Solid Tumor Drug Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Solid Tumor Drug Estimates and Projections (2021-2026)
• 10.7 Latin America Solid Tumor Drug Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Solid Tumor Drug Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List